GSC Products, LLC's Complete FDA Record

FDA action counts

Enforcement history

On 2026-05-18, Argus HQ recorded an FDA Warning Letter for GSC Products, LLC, rated "critical" severity in Argus HQ's classification: GSC Products, LLC — Nonprescription/OTC (2026-05-18). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. GSC Products, LLC has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

How many FDA actions does Argus HQ track for GSC Products, LLC?

1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for GSC Products, LLC?

May 18, 2026. Argus HQ ingests new FDA enforcement records daily.

Has GSC Products, LLC received FDA warning letters?

Yes, 1 warning letter on file. See the full history below for each one.

Is this FDA enforcement data for GSC Products, LLC official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

Related enforcement actions

• GSC Products, LLC — Nonprescription/OTC (2026-05-18) →

Compare with

• GSC Products, LLC vs Medline Industries, LP
• GSC Products, LLC vs ARROW INTERNATIONAL, LLC
• GSC Products, LLC vs Stryker Sustainability Solutions
• GSC Products, LLC vs Guardian Drug Co. Inc.
• GSC Products, LLC vs B BRAUN MEDICAL INC